FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to ophthalmology, and aims at treating eye discomfort. Treating the eye discomfort is ensured by applying a liquid composition containing a cooling agent. The cooling agent represents 2,3-dihydroxypropyl ester of (1R,2S,5R)-2-isopropyl-5-methylcyclohexane carboxylic acid (or CPS-030). The liquid composition of the cooling agent is applied locally on at least a part of the outer surface of the eyelid (preferentially a closed one) to be treated. Preferentially, the liquid composition of the cooling agent is applied on a tissue, a tampon or a wipe or is enclosed into a tissue, a tampon or a wipe, e.g. an eye wipe.
EFFECT: using the group of inventions provides the prolonged relief of the eye discomfort with no eye irritation.
57 cl, 1 tbl, 1 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ISOPROPYL ESTER OF [(1R,2S,5R)-2-ISOPROPYL-5-METHYLCYCLOHEXANECARBONYL)-AMINO]-ACETIC ACID, RELATED COMPOUNDS AND USE THEREOF IN THERAPY | 2011 |
|
RU2598644C2 |
| N-ALKYLCARBONYLAMINOACID ETHERS AND N-ALKYLCARBONYLAMINOLACTONS AND APPLICATION THEREOF | 2006 |
|
RU2417218C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
| OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCULAR SURFACE DAMAGE AND DRY EYE SYMPTOMS | 2019 |
|
RU2806212C2 |
| THERAPEUTIC AGENT FOR MEIBOMIAN GLAND DYSFUNCTION | 2014 |
|
RU2709542C2 |
| ARTIFICIAL TEARS AND THERAPEUTIC APPLICATION | 2010 |
|
RU2589837C2 |
| OPHTHALMIC PREPARATION | 2017 |
|
RU2782456C2 |
| OPHTHALMIC COMPOSITIONS CONTAINING PROSTAMIDE RELEASING NITROGEN OXIDE | 2019 |
|
RU2781022C2 |
| NON-INVASIVE MEDICINE DELIVERY TECHNIQUE USING EYE INLAY | 2017 |
|
RU2749426C2 |
| NEW USE OF NICOTINAMIDE MONONUCLETIDE (NMN) AND NICOTINAMIDE RIBOSIDE (NR) | 2020 |
|
RU2822512C2 |
